Response to: 'Is it time to redefine the role of low-dose radiotherapy for benign disease?' by Montero et al.

Elien A M MahlerMichiel Jm MintenMathilde M Leseman-HoogenboomPhilip M P PoortmansJan Willem LeerSimone S BoksFrank H J van den HoogenAlfons A den BroederCornelia H van den Ende

Published in: Annals of the rheumatic diseases (2019)

Keyphrases

low dose
early stage
high dose
locally advanced
radiation therapy
radiation induced
squamous cell carcinoma